122 related articles for article (PubMed ID: 12893077)
1. Microphysiological testing for chemosensitivity of living tumor cells with multiparametric microsensor chips.
Otto AM; Brischwein M; Niendorf A; Henning T; Motrescu E; Wolf B
Cancer Detect Prev; 2003; 27(4):291-6. PubMed ID: 12893077
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric sensor chips for chemosensitivity testing of sensitive and resistant tumor cells.
Otto AM; Brischwein M; Grothe H; Motrescu E; Wolf B
Recent Results Cancer Res; 2003; 161():39-47. PubMed ID: 12528797
[TBL] [Abstract][Full Text] [Related]
3. Analysis of drug action on tumor cell metabolism using electronic sensor chips.
Otto AM; Brischwein M; Motrescu E; Wolf B
Arch Pharm (Weinheim); 2004 Dec; 337(12):682-6. PubMed ID: 15597401
[TBL] [Abstract][Full Text] [Related]
4. Functional cellular assays with multiparametric silicon sensor chips.
Brischwein M; Motrescu ER; Cabala E; Otto AM; Grothe H; Wolf B
Lab Chip; 2003 Nov; 3(4):234-40. PubMed ID: 15007452
[TBL] [Abstract][Full Text] [Related]
5. Application of silicon sensor technologies to tumor tissue in vitro: detection of metabolic correlates of chemosensitivity.
Mestres-Ventura P; Morguet A; Schofer A; Laue M; Schmidt W
Methods Mol Med; 2005; 111():109-25. PubMed ID: 15911976
[TBL] [Abstract][Full Text] [Related]
6. Approach to a multiparametric sensor-chip-based tumor chemosensitivity assay.
Henning T; Brischwein M; Baumann W; Ehret R; Freund I; Kammerer R; Lehmann M; Schwinde A; Wolf B
Anticancer Drugs; 2001 Jan; 12(1):21-32. PubMed ID: 11272283
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric sensor-chip based technology for monitoring metabolic activity: A proof-of-principle study with live tissue.
Sprague LD; Beregov V; Von Sternbach G; Brischwein M; Otto AM; Adam M; Wolf B; Molls M
Clin Lab; 2006; 52(7-8):375-84. PubMed ID: 16955636
[TBL] [Abstract][Full Text] [Related]
8. In vitro characterisation of soft tissue tumor chemosensitivity.
Remmelink M; Salmon I; Delville JP; Goldschmidt D; Capel P; Gebhart M; Pasteels JL; Kiss R; Darro F
Anticancer Res; 1997; 17(3C):2009-17. PubMed ID: 9216658
[TBL] [Abstract][Full Text] [Related]
9. [Chemosensitivity test of breast cancer].
Oura S; Tanino H; Naito Y
Nihon Rinsho; 2000 Apr; 58 Suppl():581-6. PubMed ID: 11026054
[No Abstract] [Full Text] [Related]
10. Sensor-based cell and tissue screening for personalized cancer chemotherapy.
Kleinhans R; Brischwein M; Wang P; Becker B; Demmel F; Schwarzenberger T; Zottmann M; Wolf P; Niendorf A; Wolf B
Med Biol Eng Comput; 2012 Feb; 50(2):117-26. PubMed ID: 22290601
[TBL] [Abstract][Full Text] [Related]
11. [Chips instead of mice: cells on bioelectronic sensor-chips as an alternative to animal experiments].
Otto AM; Brischwein M; Motrescu E; Cabala E; Grothe H; Stepper C; Wolf B
ALTEX; 2004; 21 Suppl 3():70-6. PubMed ID: 15057411
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitivity testing of human tumors using Si-sensor chips.
Mestres-Ventura P
Recent Results Cancer Res; 2003; 161():26-38. PubMed ID: 12528796
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I receptor activation blocks doxorubicin cytotoxicity in sarcoma cells.
Beech DJ; Perer E; Helms J; Gratzer A; Deng N
Oncol Rep; 2003; 10(1):181-4. PubMed ID: 12469167
[TBL] [Abstract][Full Text] [Related]
14. In vitro chemosensitivity testing of primary and recurrent breast carcinomas and its clinical significance.
Li Z; Song H; He W; Tian Y; Huang T
J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):683-7. PubMed ID: 19107367
[TBL] [Abstract][Full Text] [Related]
15. [A study of MTT-hybrid assay using human bone and soft tissue tumor cells].
Kawai A; Ito S; Ozaki T; Inoue H; Tanabe G; Sato J
Hum Cell; 1989 Sep; 2(3):283-9. PubMed ID: 2519217
[TBL] [Abstract][Full Text] [Related]
16. Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil) in soft tissue sarcoma-bearing rats.
ten Hagen TL; Seynhaeve AL; van Tiel ST; Ruiter DJ; Eggermont AM
Int J Cancer; 2002 Jan; 97(1):115-20. PubMed ID: 11774252
[TBL] [Abstract][Full Text] [Related]
17. Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity.
Bernhardt G; Reile H; Birnböck H; Spruss T; Schönenberger H
J Cancer Res Clin Oncol; 1992; 118(1):35-43. PubMed ID: 1309532
[TBL] [Abstract][Full Text] [Related]
18. In vitro chemosensitivity of human soft tissue sarcoma.
Morioka H; Yabe H; Morii T; Yamada R; Kato S; Yuasa S; Yano T
Anticancer Res; 2001; 21(6A):4147-51. PubMed ID: 11911309
[TBL] [Abstract][Full Text] [Related]
19. Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.
Murata H; Kusuzaki K; Takeshita H; Hirata M; Hashiguchi S; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(5C):3967-70. PubMed ID: 11268485
[TBL] [Abstract][Full Text] [Related]
20. Testing of a chemosensitivity screening method on sensitive and resistant breast tumoral epithelial cell lines.
Colomb E; Martin PM
Anal Cell Pathol; 1994 Feb; 6(2):105-16. PubMed ID: 8167093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
